Skip to content

Holy basil and perceived stress: grade B

Moderate evidence. Direction: Benefit.

B ModerateIndustry-fundedShort-term only

Why this grade

Rubric condition met: One randomized, double-blind, placebo-controlled RCT with n >= 100, positive on its prespecified primary outcome (PSS) and with known funding (n = 100 randomized, 85 completed; the editor counts randomized n); a second RCT, tied to the same supplier, points the same way

In a preregistered 8-week trial that randomized 100 adults with stress and poor sleep (15 withdrew), 250 mg/day of the Holixer extract lowered Perceived Stress Scale scores more than placebo, with lower hair cortisol at week 8. A 6-week trial in 150 adults with stress symptoms found larger reductions in a symptom score, on a scale the paper does not describe as validated, with 1,200 mg/day of OciBest. Both extracts come from Natural Remedies, which funded the first trial and employed three authors of the second, so no independent trial supports the grade, and neither trial ran longer than 8 weeks. No meta-analysis was found (PubMed and Europe PMC searches, November 11, 2026).

How we grade evidence

Studies this grade rests on

EffectMixedNo effectSize shows participants (n)2010201520202025RCTSaxena 2012, 2012: RCT, n = 150, result not recordedLopresti 2022, 2022: RCT, n = 100, result not recorded
each study this grade rests on, by publication year and design. Solid: effect versus the comparator; half-filled: mixed; hollow: no effect; dashed: result not recorded yet. Larger marks had more participants.
Show the numbers
StudyYearDesignParticipantsResult
Saxena 20122012RCT150result not recorded
Lopresti 20222022RCT100result not recorded

Efficacy of an Extract of Ocimum tenuiflorum (OciBest) in the Management of General Stress: A Double-Blind, Placebo-Controlled Study.

Saxena RC, Singh R, Kumar P. Efficacy of an Extract of Ocimum tenuiflorum (OciBest) in the Management of General Stress: A Double-Blind, Placebo-Controlled Study Evid Based Complement Alternat Med, 2012. PMID 21977056

Result not recorded
Design
Randomized, double-blind, placebo-controlled trial (6 weeks)
Sample
n = 150
Population
Adults with symptoms of general stress (two centers in Lucknow, India)
Funding
Funding not stated in the paper; three co-authors are at the Research and Development Centre of Natural Remedies, which developed OciBest

A randomized, double-blind, placebo-controlled trial investigating the effects of an Ocimum tenuiflorum (Holy Basil) extract (Holixer(TM)) on stress, mood, and sleep in adults experiencing stress.

Lopresti AL, Smith SJ, Metse AP. A randomized, double-blind, placebo-controlled trial investigating the effects of an Ocimum tenuiflorum (Holy Basil) extract (Holixer(TM)) on stress, mood, and sleep in adults experiencing stress Front Nutr, 2022. PMID 36185698

Result not recorded
Design
Randomized, double-blind, placebo-controlled, two-arm parallel-group trial (8 weeks)
Sample
n = 100
Population
Adults aged 18-65 experiencing stress for over a month and current sleep problems (PSS 14 or higher)
Funding
Natural Remedies Pty Ltd (maker of the Holixer extract), which also supplied the capsules

Search and history

Search (): (holy basil[tiab] OR tulsi[tiab] OR "Ocimum sanctum"[tiab] OR "Ocimum tenuiflorum"[tiab]) AND (stress[tiab] OR anxiety[tiab] OR mood[tiab]) AND (randomized[tiab] OR placebo[tiab])

  • Graded B (proposed): Proposed in the monograph draft
  • B to B (approved): Editor sign-off November 13, 2026: grade matches the editor-approved final page